Medical Care

Global Zebrafish Disease Models Market Research Report 2025

The global market for Zebrafish Disease Models was valued at US$ 26.5 million in the year 2024 and is projected to reach a revised size of US$ 37.2 million by 2031, growing at a CAGR of 5.0% during the forecast period.
The zebrafish is an important and widely used vertebrate model organism in scientific research, for example in drug development, in particular pre-clinical development. It is also notable for its regenerative abilities, and has been modified by researchers to produce many transgenic strains.
North American market for Zebrafish Disease Models is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Zebrafish Disease Models is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Zebrafish Disease Models in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Zebrafish Disease Models include Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, Ikan Biotech, Bioreperia, Hangzhou Hunter Biotechnology Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Zebrafish Disease Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zebrafish Disease Models.
The Zebrafish Disease Models market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Zebrafish Disease Models market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zebrafish Disease Models companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai Model Organisms Center, Inc.
ZeClinics
InVivo Biosystems
Biobide
Pentagrit
Evotec
Aurigene Pharmaceutical Services
Ikan Biotech
Bioreperia
Hangzhou Hunter Biotechnology Co., Ltd.
YSY BIOTECH
Eze-Rinka
INVENesis
FEIFAN TEST
Charles River Laboratories
Segment by Type
Epilepsy Model
Parkinson Disease Model
Retinal Degeneration Model
Metabolic Disorders and Obesity Model
Segment by Application
Pharmaceutical
Biotechnology
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Zebrafish Disease Models company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Zebrafish Disease Models Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Epilepsy Model
1.2.3 Parkinson Disease Model
1.2.4 Retinal Degeneration Model
1.2.5 Metabolic Disorders and Obesity Model
1.3 Market by Application
1.3.1 Global Zebrafish Disease Models Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Zebrafish Disease Models Market Perspective (2020-2031)
2.2 Global Zebrafish Disease Models Growth Trends by Region
2.2.1 Global Zebrafish Disease Models Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Zebrafish Disease Models Historic Market Size by Region (2020-2025)
2.2.3 Zebrafish Disease Models Forecasted Market Size by Region (2026-2031)
2.3 Zebrafish Disease Models Market Dynamics
2.3.1 Zebrafish Disease Models Industry Trends
2.3.2 Zebrafish Disease Models Market Drivers
2.3.3 Zebrafish Disease Models Market Challenges
2.3.4 Zebrafish Disease Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Zebrafish Disease Models Players by Revenue
3.1.1 Global Top Zebrafish Disease Models Players by Revenue (2020-2025)
3.1.2 Global Zebrafish Disease Models Revenue Market Share by Players (2020-2025)
3.2 Global Zebrafish Disease Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Zebrafish Disease Models Revenue
3.4 Global Zebrafish Disease Models Market Concentration Ratio
3.4.1 Global Zebrafish Disease Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Zebrafish Disease Models Revenue in 2024
3.5 Global Key Players of Zebrafish Disease Models Head office and Area Served
3.6 Global Key Players of Zebrafish Disease Models, Product and Application
3.7 Global Key Players of Zebrafish Disease Models, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Zebrafish Disease Models Breakdown Data by Type
4.1 Global Zebrafish Disease Models Historic Market Size by Type (2020-2025)
4.2 Global Zebrafish Disease Models Forecasted Market Size by Type (2026-2031)
5 Zebrafish Disease Models Breakdown Data by Application
5.1 Global Zebrafish Disease Models Historic Market Size by Application (2020-2025)
5.2 Global Zebrafish Disease Models Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Zebrafish Disease Models Market Size (2020-2031)
6.2 North America Zebrafish Disease Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Zebrafish Disease Models Market Size by Country (2020-2025)
6.4 North America Zebrafish Disease Models Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Zebrafish Disease Models Market Size (2020-2031)
7.2 Europe Zebrafish Disease Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Zebrafish Disease Models Market Size by Country (2020-2025)
7.4 Europe Zebrafish Disease Models Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Zebrafish Disease Models Market Size (2020-2031)
8.2 Asia-Pacific Zebrafish Disease Models Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Zebrafish Disease Models Market Size by Region (2020-2025)
8.4 Asia-Pacific Zebrafish Disease Models Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Zebrafish Disease Models Market Size (2020-2031)
9.2 Latin America Zebrafish Disease Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Zebrafish Disease Models Market Size by Country (2020-2025)
9.4 Latin America Zebrafish Disease Models Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Zebrafish Disease Models Market Size (2020-2031)
10.2 Middle East & Africa Zebrafish Disease Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Zebrafish Disease Models Market Size by Country (2020-2025)
10.4 Middle East & Africa Zebrafish Disease Models Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Model Organisms Center, Inc.
11.1.1 Shanghai Model Organisms Center, Inc. Company Details
11.1.2 Shanghai Model Organisms Center, Inc. Business Overview
11.1.3 Shanghai Model Organisms Center, Inc. Zebrafish Disease Models Introduction
11.1.4 Shanghai Model Organisms Center, Inc. Revenue in Zebrafish Disease Models Business (2020-2025)
11.1.5 Shanghai Model Organisms Center, Inc. Recent Development
11.2 ZeClinics
11.2.1 ZeClinics Company Details
11.2.2 ZeClinics Business Overview
11.2.3 ZeClinics Zebrafish Disease Models Introduction
11.2.4 ZeClinics Revenue in Zebrafish Disease Models Business (2020-2025)
11.2.5 ZeClinics Recent Development
11.3 InVivo Biosystems
11.3.1 InVivo Biosystems Company Details
11.3.2 InVivo Biosystems Business Overview
11.3.3 InVivo Biosystems Zebrafish Disease Models Introduction
11.3.4 InVivo Biosystems Revenue in Zebrafish Disease Models Business (2020-2025)
11.3.5 InVivo Biosystems Recent Development
11.4 Biobide
11.4.1 Biobide Company Details
11.4.2 Biobide Business Overview
11.4.3 Biobide Zebrafish Disease Models Introduction
11.4.4 Biobide Revenue in Zebrafish Disease Models Business (2020-2025)
11.4.5 Biobide Recent Development
11.5 Pentagrit
11.5.1 Pentagrit Company Details
11.5.2 Pentagrit Business Overview
11.5.3 Pentagrit Zebrafish Disease Models Introduction
11.5.4 Pentagrit Revenue in Zebrafish Disease Models Business (2020-2025)
11.5.5 Pentagrit Recent Development
11.6 Evotec
11.6.1 Evotec Company Details
11.6.2 Evotec Business Overview
11.6.3 Evotec Zebrafish Disease Models Introduction
11.6.4 Evotec Revenue in Zebrafish Disease Models Business (2020-2025)
11.6.5 Evotec Recent Development
11.7 Aurigene Pharmaceutical Services
11.7.1 Aurigene Pharmaceutical Services Company Details
11.7.2 Aurigene Pharmaceutical Services Business Overview
11.7.3 Aurigene Pharmaceutical Services Zebrafish Disease Models Introduction
11.7.4 Aurigene Pharmaceutical Services Revenue in Zebrafish Disease Models Business (2020-2025)
11.7.5 Aurigene Pharmaceutical Services Recent Development
11.8 Ikan Biotech
11.8.1 Ikan Biotech Company Details
11.8.2 Ikan Biotech Business Overview
11.8.3 Ikan Biotech Zebrafish Disease Models Introduction
11.8.4 Ikan Biotech Revenue in Zebrafish Disease Models Business (2020-2025)
11.8.5 Ikan Biotech Recent Development
11.9 Bioreperia
11.9.1 Bioreperia Company Details
11.9.2 Bioreperia Business Overview
11.9.3 Bioreperia Zebrafish Disease Models Introduction
11.9.4 Bioreperia Revenue in Zebrafish Disease Models Business (2020-2025)
11.9.5 Bioreperia Recent Development
11.10 Hangzhou Hunter Biotechnology Co., Ltd.
11.10.1 Hangzhou Hunter Biotechnology Co., Ltd. Company Details
11.10.2 Hangzhou Hunter Biotechnology Co., Ltd. Business Overview
11.10.3 Hangzhou Hunter Biotechnology Co., Ltd. Zebrafish Disease Models Introduction
11.10.4 Hangzhou Hunter Biotechnology Co., Ltd. Revenue in Zebrafish Disease Models Business (2020-2025)
11.10.5 Hangzhou Hunter Biotechnology Co., Ltd. Recent Development
11.11 YSY BIOTECH
11.11.1 YSY BIOTECH Company Details
11.11.2 YSY BIOTECH Business Overview
11.11.3 YSY BIOTECH Zebrafish Disease Models Introduction
11.11.4 YSY BIOTECH Revenue in Zebrafish Disease Models Business (2020-2025)
11.11.5 YSY BIOTECH Recent Development
11.12 Eze-Rinka
11.12.1 Eze-Rinka Company Details
11.12.2 Eze-Rinka Business Overview
11.12.3 Eze-Rinka Zebrafish Disease Models Introduction
11.12.4 Eze-Rinka Revenue in Zebrafish Disease Models Business (2020-2025)
11.12.5 Eze-Rinka Recent Development
11.13 INVENesis
11.13.1 INVENesis Company Details
11.13.2 INVENesis Business Overview
11.13.3 INVENesis Zebrafish Disease Models Introduction
11.13.4 INVENesis Revenue in Zebrafish Disease Models Business (2020-2025)
11.13.5 INVENesis Recent Development
11.14 FEIFAN TEST
11.14.1 FEIFAN TEST Company Details
11.14.2 FEIFAN TEST Business Overview
11.14.3 FEIFAN TEST Zebrafish Disease Models Introduction
11.14.4 FEIFAN TEST Revenue in Zebrafish Disease Models Business (2020-2025)
11.14.5 FEIFAN TEST Recent Development
11.15 Charles River Laboratories
11.15.1 Charles River Laboratories Company Details
11.15.2 Charles River Laboratories Business Overview
11.15.3 Charles River Laboratories Zebrafish Disease Models Introduction
11.15.4 Charles River Laboratories Revenue in Zebrafish Disease Models Business (2020-2025)
11.15.5 Charles River Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Zebrafish Disease Models Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Epilepsy Model
Table 3. Key Players of Parkinson Disease Model
Table 4. Key Players of Retinal Degeneration Model
Table 5. Key Players of Metabolic Disorders and Obesity Model
Table 6. Global Zebrafish Disease Models Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Zebrafish Disease Models Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Zebrafish Disease Models Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Zebrafish Disease Models Market Share by Region (2020-2025)
Table 10. Global Zebrafish Disease Models Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Zebrafish Disease Models Market Share by Region (2026-2031)
Table 12. Zebrafish Disease Models Market Trends
Table 13. Zebrafish Disease Models Market Drivers
Table 14. Zebrafish Disease Models Market Challenges
Table 15. Zebrafish Disease Models Market Restraints
Table 16. Global Zebrafish Disease Models Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Zebrafish Disease Models Market Share by Players (2020-2025)
Table 18. Global Top Zebrafish Disease Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zebrafish Disease Models as of 2024)
Table 19. Ranking of Global Top Zebrafish Disease Models Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Zebrafish Disease Models Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Zebrafish Disease Models, Headquarters and Area Served
Table 22. Global Key Players of Zebrafish Disease Models, Product and Application
Table 23. Global Key Players of Zebrafish Disease Models, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Zebrafish Disease Models Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Zebrafish Disease Models Revenue Market Share by Type (2020-2025)
Table 27. Global Zebrafish Disease Models Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Zebrafish Disease Models Revenue Market Share by Type (2026-2031)
Table 29. Global Zebrafish Disease Models Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Zebrafish Disease Models Revenue Market Share by Application (2020-2025)
Table 31. Global Zebrafish Disease Models Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Zebrafish Disease Models Revenue Market Share by Application (2026-2031)
Table 33. North America Zebrafish Disease Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Zebrafish Disease Models Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Zebrafish Disease Models Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Zebrafish Disease Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Zebrafish Disease Models Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Zebrafish Disease Models Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Zebrafish Disease Models Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Zebrafish Disease Models Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Zebrafish Disease Models Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Zebrafish Disease Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Zebrafish Disease Models Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Zebrafish Disease Models Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Zebrafish Disease Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Zebrafish Disease Models Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Zebrafish Disease Models Market Size by Country (2026-2031) & (US$ Million)
Table 48. Shanghai Model Organisms Center, Inc. Company Details
Table 49. Shanghai Model Organisms Center, Inc. Business Overview
Table 50. Shanghai Model Organisms Center, Inc. Zebrafish Disease Models Product
Table 51. Shanghai Model Organisms Center, Inc. Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 52. Shanghai Model Organisms Center, Inc. Recent Development
Table 53. ZeClinics Company Details
Table 54. ZeClinics Business Overview
Table 55. ZeClinics Zebrafish Disease Models Product
Table 56. ZeClinics Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 57. ZeClinics Recent Development
Table 58. InVivo Biosystems Company Details
Table 59. InVivo Biosystems Business Overview
Table 60. InVivo Biosystems Zebrafish Disease Models Product
Table 61. InVivo Biosystems Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 62. InVivo Biosystems Recent Development
Table 63. Biobide Company Details
Table 64. Biobide Business Overview
Table 65. Biobide Zebrafish Disease Models Product
Table 66. Biobide Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 67. Biobide Recent Development
Table 68. Pentagrit Company Details
Table 69. Pentagrit Business Overview
Table 70. Pentagrit Zebrafish Disease Models Product
Table 71. Pentagrit Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 72. Pentagrit Recent Development
Table 73. Evotec Company Details
Table 74. Evotec Business Overview
Table 75. Evotec Zebrafish Disease Models Product
Table 76. Evotec Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 77. Evotec Recent Development
Table 78. Aurigene Pharmaceutical Services Company Details
Table 79. Aurigene Pharmaceutical Services Business Overview
Table 80. Aurigene Pharmaceutical Services Zebrafish Disease Models Product
Table 81. Aurigene Pharmaceutical Services Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 82. Aurigene Pharmaceutical Services Recent Development
Table 83. Ikan Biotech Company Details
Table 84. Ikan Biotech Business Overview
Table 85. Ikan Biotech Zebrafish Disease Models Product
Table 86. Ikan Biotech Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 87. Ikan Biotech Recent Development
Table 88. Bioreperia Company Details
Table 89. Bioreperia Business Overview
Table 90. Bioreperia Zebrafish Disease Models Product
Table 91. Bioreperia Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 92. Bioreperia Recent Development
Table 93. Hangzhou Hunter Biotechnology Co., Ltd. Company Details
Table 94. Hangzhou Hunter Biotechnology Co., Ltd. Business Overview
Table 95. Hangzhou Hunter Biotechnology Co., Ltd. Zebrafish Disease Models Product
Table 96. Hangzhou Hunter Biotechnology Co., Ltd. Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 97. Hangzhou Hunter Biotechnology Co., Ltd. Recent Development
Table 98. YSY BIOTECH Company Details
Table 99. YSY BIOTECH Business Overview
Table 100. YSY BIOTECH Zebrafish Disease Models Product
Table 101. YSY BIOTECH Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 102. YSY BIOTECH Recent Development
Table 103. Eze-Rinka Company Details
Table 104. Eze-Rinka Business Overview
Table 105. Eze-Rinka Zebrafish Disease Models Product
Table 106. Eze-Rinka Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 107. Eze-Rinka Recent Development
Table 108. INVENesis Company Details
Table 109. INVENesis Business Overview
Table 110. INVENesis Zebrafish Disease Models Product
Table 111. INVENesis Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 112. INVENesis Recent Development
Table 113. FEIFAN TEST Company Details
Table 114. FEIFAN TEST Business Overview
Table 115. FEIFAN TEST Zebrafish Disease Models Product
Table 116. FEIFAN TEST Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 117. FEIFAN TEST Recent Development
Table 118. Charles River Laboratories Company Details
Table 119. Charles River Laboratories Business Overview
Table 120. Charles River Laboratories Zebrafish Disease Models Product
Table 121. Charles River Laboratories Revenue in Zebrafish Disease Models Business (2020-2025) & (US$ Million)
Table 122. Charles River Laboratories Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report


List of Figures
Figure 1. Zebrafish Disease Models Picture
Figure 2. Global Zebrafish Disease Models Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Zebrafish Disease Models Market Share by Type: 2024 VS 2031
Figure 4. Epilepsy Model Features
Figure 5. Parkinson Disease Model Features
Figure 6. Retinal Degeneration Model Features
Figure 7. Metabolic Disorders and Obesity Model Features
Figure 8. Global Zebrafish Disease Models Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Zebrafish Disease Models Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Case Studies
Figure 11. Biotechnology Case Studies
Figure 12. Zebrafish Disease Models Report Years Considered
Figure 13. Global Zebrafish Disease Models Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Zebrafish Disease Models Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Zebrafish Disease Models Market Share by Region: 2024 VS 2031
Figure 16. Global Zebrafish Disease Models Market Share by Players in 2024
Figure 17. Global Top Zebrafish Disease Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zebrafish Disease Models as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Zebrafish Disease Models Revenue in 2024
Figure 19. North America Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Zebrafish Disease Models Market Share by Country (2020-2031)
Figure 21. United States Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Zebrafish Disease Models Market Share by Country (2020-2031)
Figure 25. Germany Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Zebrafish Disease Models Market Share by Region (2020-2031)
Figure 33. China Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Zebrafish Disease Models Market Share by Country (2020-2031)
Figure 41. Mexico Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Zebrafish Disease Models Market Share by Country (2020-2031)
Figure 45. Turkey Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Zebrafish Disease Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Shanghai Model Organisms Center, Inc. Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 49. ZeClinics Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 50. InVivo Biosystems Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 51. Biobide Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 52. Pentagrit Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 53. Evotec Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 54. Aurigene Pharmaceutical Services Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 55. Ikan Biotech Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 56. Bioreperia Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 57. Hangzhou Hunter Biotechnology Co., Ltd. Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 58. YSY BIOTECH Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 59. Eze-Rinka Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 60. INVENesis Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 61. FEIFAN TEST Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 62. Charles River Laboratories Revenue Growth Rate in Zebrafish Disease Models Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies